Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Infinitopes is an integrated cancer biotechnology company spun out from the University of Oxford and supported by Cancer Research UK. The company combines precision antigen discovery with high-efficiency vector delivery systems using its proprietary AI/ML-driven Precision Immunomics™ platform to identify and target tumor-specific antigens. Infinitopes is advancing immunologically durable cancer vaccines, including its lead c...
Infinitopes is an integrated cancer biotechnology company spun out from the University of Oxford and supported by Cancer Research UK. The company combines precision antigen discovery with high-efficiency vector delivery systems using its proprietary AI/ML-driven Precision Immunomics™ platform to identify and target tumor-specific antigens. Infinitopes is advancing immunologically durable cancer vaccines, including its lead candidate ITOP1, toward clinical development to prevent disease recurrence and improve patient outcomes.

List your booth number for exhibitions, ask us